Clinical Trial

Evaluating the Efficacy and Tolerability of ZED1227 in Subjects With Non-responsive Celiac Disease

Name: Evaluating the Efficacy and Tolerability of ZED1227 in Subjects With Non-responsive Celiac Disease — clinical trial record (NCT07298343)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: CEC-013/CEL

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

A study to discover if ZED1227 can improve continued celiac disease symptoms despite a gluten-free diet

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-12-19.

Status change: Active, Not Recruiting → Recruiting 2026-04-01

Trial Details

NCT Number	NCT07298343
Lead Sponsor	Dr. Falk Pharma GmbH Collaborators: Takeda Development Center Americas, Inc.
Conditions	Celiac Disease
Enrollment	356 participants
Start Date	2024-06-10
Primary Completion	2027-08 (estimated)
Study Completion	2027-08 (estimated)
Updated on ClinicalTrials.gov	2026-04-02